Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by identifying an existing drug with the potential to prevent deadly heart ...

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new ...

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments.

sold as Lexapro, may prevent harmful changes in the heart that lead to heart failure, a condition that causes almost half of all cardiovascular deaths in the United States. “AI needs to move ...

He has been tapering off lithium for nine months under the care of a nurse-practitioner, and settled, for the moment, at 450 milligrams, half his original ... to taper off Lexapro himself.

Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...